Add like
Add dislike
Add to saved papers

Identifying hospitalized infants who have bronchiolitis and are at high risk for apnea.

STUDY OBJECTIVE: Young infants with bronchiolitis are at risk for apnea. We seek to determine the rate of apnea in young infants with bronchiolitis and evaluate the performance of a predefined set of risk criteria for identifying infants at high risk for the development of apnea.

METHODS: We identified a retrospective cohort study of patients treated in the emergency department (ED) of an urban pediatric tertiary care hospital from November 1995 to June 2000. All infants younger than 6 months who met our study definition of bronchiolitis and were admitted to the hospital were included. We developed, a priori, a set of risk criteria for identifying patients at high risk for apnea. Children were considered to be at high risk for apnea if (1) they were born at full term and were younger than 1 month, (2) they were born preterm (<37 weeks estimated gestational age) and were younger than 48 weeks postconception, or (3) the child's parents or a clinician had already witnessed an apnea episode with this illness before inpatient admission. Data pertaining to these risk criteria were collected from the ED physician's note. The primary outcome variable, the development of inhospital apnea, was assessed by review of the inpatient discharge summaries and medical records.

RESULTS: Nineteen of 691 (2.7%; 95% confidence interval [CI] 1.7% to 4.3%) infants admitted with bronchiolitis developed apnea while hospitalized. All 19 patients with apnea were identified by our risk criteria (100% sensitivity; 1-sided 97.5% CI 82% to 100%). No patient classified as low risk subsequently developed apnea (100% negative predictive value; 1-sided 97.5% CI 99% to 100%).

CONCLUSION: The rate of apnea among young infants hospitalized with bronchiolitis is low. Our clinical risk criteria successfully identified a low-risk group of infants whose risk of apnea is less than 1%.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app